BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32317521)

  • 21. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
    Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
    Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells.
    Kramer G; Steiner GE; Gröbl M; Hrachowitz K; Reithmayr F; Paucz L; Newman M; Madersbacher S; Gruber D; Susani M; Marberger M
    Prostate; 2004 Feb; 58(2):109-20. PubMed ID: 14716736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen.
    Moussa M; Kloth D; Peers G; Cherian MG; Frei JV; Chin JL
    Clin Invest Med; 1997 Dec; 20(6):371-80. PubMed ID: 9413634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat shock protein 90 is associated with hyperplasia and neoplastic transformation of canine prostatic epithelial cells.
    Palmieri C; Mancini M; Benazzi C; Della Salda L
    J Comp Pathol; 2014 May; 150(4):393-8. PubMed ID: 24679854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
    Abdou AG; Aiad HA; Sultan SM
    APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Significance of High Androgen Receptor Expression in Prostatic Acinar Adenocarcinoma.
    Hashmi AA; Mudassir G; Irfan M; Hussain ZF; Hashmi SK; Asif H; Nisar L; Naeem M; Faridi N
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):893-896. PubMed ID: 30912411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer.
    Xu N; Chen HJ; Chen SH; Xue XY; Chen H; Zheng QS; Wei Y; Li XD; Huang JB; Cai H; Sun XL
    Medicine (Baltimore); 2016 Jul; 95(29):e4326. PubMed ID: 27442684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
    Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CIP2A expression in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue mıcroarray study.
    Celikden SG; Baspinar S; Ozturk SA; Karaibrahimoglu A
    Malays J Pathol; 2020 Aug; 42(2):227-236. PubMed ID: 32860375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Heat Shock Protein 27 in Benign Prostatic Hyperplasia with Chronic Inflammation.
    Jiang Y; Wang X; Guo Y; Li W; Yang S; Li W; Cai W
    Med Sci Monit; 2015 Oct; 21():2976-85. PubMed ID: 26434601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
    Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
    Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of NGF, GDNF and MMP-9 in prostate carcinoma.
    Baspinar S; Bircan S; Ciris M; Karahan N; Bozkurt KK
    Pathol Res Pract; 2017 May; 213(5):483-489. PubMed ID: 28237042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of Cyclin D1 among Sudanese patients diagnosed with benign and malignant prostatic lesions.
    Ahmed ES; Elnour LS; Hassan R; Siddig EE; Chacko ME; Ali ET; Mohamed MA; Munir A; Muneer MS; Mohamed NS; Edris AMM
    BMC Res Notes; 2020 Jun; 13(1):295. PubMed ID: 32552908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.
    Singer E; Linehan J; Babilonia G; Imam SA; Smith D; Loera S; Wilson T; Smith S
    PLoS One; 2013; 8(6):e60562. PubMed ID: 23762225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate Cancer predict prostatic disease progression.
    Li Q; Shi Y; Sa R; Hao J; Hu J; Xiao M; Wang C; Yan L; Qiao B; Chen G
    BMC Cancer; 2020 Jun; 20(1):555. PubMed ID: 32539763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death.
    Mortezavi A; Salemi S; Rupp NJ; Rüschoff JH; Hermanns T; Poyet C; Randazzo M; Simon HU; Moch H; Sulser T; Wild P; Eberli D
    Oncotarget; 2017 May; 8(19):31765-31774. PubMed ID: 28423666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of IL-10+CD19+ B cells in patients with prostate cancer compared to patients with benign prostatic hyperplasia.
    Roya N; Fatemeh T; Faramarz MA; Milad SG; Mohammad-Javad S; Najmeh SV; Yousef M; Nader B
    Afr Health Sci; 2020 Sep; 20(3):1264-1272. PubMed ID: 33402974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues.
    Chang SS; Reuter VE; Heston WD; Hutchinson B; Grauer LS; Gaudin PB
    Cancer; 2000 Jan; 88(2):407-15. PubMed ID: 10640975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
    Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E
    Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.
    Vasiljević N; Ahmad AS; Beesley C; Thorat MA; Fisher G; Berney DM; Møller H; Yu Y; Lu YJ; Cuzick J; Foster CS; Lorincz AT
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):35-40. PubMed ID: 23165430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.